Literature DB >> 16288933

Chemotherapeutic efficacy of ascofuranone in Trypanosoma vivax-infected mice without glycerol.

Yoshisada Yabu1, Takashi Suzuki, Coh-ichi Nihei, Nobuko Minagawa, Tomoyoshi Hosokawa, Kazuo Nagai, Kiyoshi Kita, Nobuo Ohta.   

Abstract

Ascofuranone, an antibiotic isolated from Ascochyta visiae, showed trypanocidal activity in Trypanosoma vivax-infected mice. A single dose of 50 mg/kg ascofuranone effectively cured the mice without the help of glycerol. Repeated administrations of this drug further enhanced its chemotherapeutic effect. After two, three, and four consecutive days treatment, the doses needed to cure the infection decreased to 25, 12, and 6 mg/kg, so that the total doses administered were 50, 36 and 24 mg/kg, respectively. Ascofuranone (50 mg/kg) also had a prophylactic effect against T. vivax infection within the first two days after administration. This prophylactic activity diminished to 80% by day 3 and completely disappeared four days after administration. Of particular interest in this study was that ascofuranone had trypanocidal activity in T. vivax-infected mice in the absence of glycerol, whereas co-administration of glycerol or repeated administrations of this drug are needed for Trypanosoma brucei brucei infection. Our present results strongly suggest that ascofuranone is also an effective tool in chemotherapy against African trypanosomiasis in domestic animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288933     DOI: 10.1016/j.parint.2005.09.003

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  10 in total

Review 1.  Mitochondria and trypanosomatids: targets and drugs.

Authors:  Lianet Monzote Fidalgo; Lars Gille
Journal:  Pharm Res       Date:  2011-09-21       Impact factor: 4.200

2.  Overproduction, purification, crystallization and preliminary X-ray diffraction analysis of Trypanosoma brucei gambiense glycerol kinase.

Authors:  Emmanuel Oluwadare Balogun; Daniel Ken Inaoka; Yasutoshi Kido; Tomoo Shiba; Takeshi Nara; Takashi Aoki; Teruki Honma; Akiko Tanaka; Masayuki Inoue; Shigeru Matsuoka; Paul A M Michels; Shigeharu Harada; Kiyoshi Kita
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-02-24

3.  Crystallization and preliminary crystallographic analysis of cyanide-insensitive alternative oxidase from Trypanosoma brucei brucei.

Authors:  Yasutoshi Kido; Tomoo Shiba; Daniel Ken Inaoka; Kimitoshi Sakamoto; Takeshi Nara; Takashi Aoki; Teruki Honma; Akiko Tanaka; Masayuki Inoue; Shigeru Matsuoka; Anthony Moore; Shigeharu Harada; Kiyoshi Kita
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-02-24

Review 4.  Targeting the alternative oxidase (AOX) for human health and food security, a pharmaceutical and agrochemical target or a rescue mechanism?

Authors:  Marten Szibor; Christina Schenkl; Mario R O Barsottini; Luke Young; Anthony L Moore
Journal:  Biochem J       Date:  2022-06-30       Impact factor: 3.766

5.  SAR of 4-Alkoxybenzoic Acid Inhibitors of the Trypanosome Alternative Oxidase.

Authors:  Alejandro Meco-Navas; Godwin U Ebiloma; Ana Martín-Domínguez; Irene Martínez-Benayas; Eduardo J Cueto-Díaz; Amani Saud Alhejely; Emmanuel O Balogun; Machi Saito; Miho Matsui; Natsumi Arai; Tomoo Shiba; Shigeharu Harada; Harry P de Koning; Christophe Dardonville
Journal:  ACS Med Chem Lett       Date:  2018-07-31       Impact factor: 4.345

6.  The Open Form Inducer Approach for Structure-Based Drug Design.

Authors:  Daniel Ken Inaoka; Maiko Iida; Toshiyuki Tabuchi; Teruki Honma; Nayoung Lee; Satoshi Hashimoto; Shigeru Matsuoka; Takefumi Kuranaga; Kazuhito Sato; Tomoo Shiba; Kimitoshi Sakamoto; Emmanuel Oluwadare Balogun; Shigeo Suzuki; Takeshi Nara; Josmar Rodrigues da Rocha; Carlos Alberto Montanari; Akiko Tanaka; Masayuki Inoue; Kiyoshi Kita; Shigeharu Harada
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

7.  Aquaglyceroporin-null trypanosomes display glycerol transport defects and respiratory-inhibitor sensitivity.

Authors:  Laura Jeacock; Nicola Baker; Natalie Wiedemar; Pascal Mäser; David Horn
Journal:  PLoS Pathog       Date:  2017-03-30       Impact factor: 6.823

8.  QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach.

Authors:  Alicia Rosell-Hidalgo; Luke Young; Anthony L Moore; Taravat Ghafourian
Journal:  J Comput Aided Mol Des       Date:  2020-12-08       Impact factor: 3.686

Review 9.  The double-edged sword in pathogenic trypanosomatids: the pivotal role of mitochondria in oxidative stress and bioenergetics.

Authors:  Rubem Figueiredo Sadok Menna-Barreto; Solange Lisboa de Castro
Journal:  Biomed Res Int       Date:  2014-03-31       Impact factor: 3.411

10.  Structure of the trypanosome cyanide-insensitive alternative oxidase.

Authors:  Tomoo Shiba; Yasutoshi Kido; Kimitoshi Sakamoto; Daniel Ken Inaoka; Chiaki Tsuge; Ryoko Tatsumi; Gen Takahashi; Emmanuel Oluwadare Balogun; Takeshi Nara; Takashi Aoki; Teruki Honma; Akiko Tanaka; Masayuki Inoue; Shigeru Matsuoka; Hiroyuki Saimoto; Anthony L Moore; Shigeharu Harada; Kiyoshi Kita
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.